PTEN is one of the most frequently deleted or mutated tumour suppressors in PCa, with an estimated incidence of 70% in metastatic PCa, causing aberrant activation of the PI3K–AKT–mTOR signalling pathway10. Here, PTEN is linked to neoplasm.